CapitalSource sees IPO of 14 mln shrs at $18-$21/shr

Mon. October 06, 2008; Posted: 06:43 AM

NEW YORK, Oct 06, 2008 (Thomson Financial via COMTEX) -- DB | Quote | Chart | News | PowerRating -- Oct 6 (Reuters) - CapitalSource Healthcare REIT on Monday registered its initial public offering of 14 million shares at an estimated price of $18 to $21 a share.

In an amended filing with the U.S Securities and Exchange Commission, the company that mainly invests in skilled nursing facilities, said Banc of America, Citigroup, Deutsche Bank Securities, KeyBanc Capital Markets, BMO Capital Markets, Cohen & Steers, JMP Securities and Sandler O'Neill Partners L.P. were underwriting the IPO.

The Westlake Village, California-based company said it applied for a New York Stock Exchange listing under the symbol "CHR."

(Reporting by Esha Dey in Bangalore; Editing by Anil D'Silva) Keywords: CAPITALSOURCEHEALTHCARE/IPO Chuck Mikolajczak cm

Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

MMMM

For full details on Deutsche Bank AG (DB) click here. Deutsche Bank AG (DB) has Short Term PowerRatings of 4. Details on Deutsche Bank AG (DB) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.